AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis
Article in Journal of Cystic Fibrosis (February 2022)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Re-imagining cystic fibrosis care: next generation thinking
Article in European Respiratory Journal (March 2020)
First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis
Article in Pulmonary Pharmacology & Therapeutics (July 2019)